Gael Moquin-Beaudry
Overview
Explore the profile of Gael Moquin-Beaudry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thuilliez C, Moquin-Beaudry G, Khneisser P, Marques Da Costa M, Karkar S, Boudhouche H, et al.
Bioinform Adv
. 2024 Jun;
4(1):vbae081.
PMID: 38915885
Motivation: Spatial transcriptomics enables the analysis of cell crosstalk in healthy and diseased organs by capturing the transcriptomic profiles of millions of cells within their spatial contexts. However, spatial transcriptomics...
2.
Maggiorani D, Le O, Lisi V, Landais S, Moquin-Beaudry G, Lavallee V, et al.
Nat Commun
. 2024 Mar;
15(1):2435.
PMID: 38499573
The potential of immune checkpoint inhibitors (ICI) may be limited in situations where immune cell fitness is impaired. Here, we show that the efficacy of cancer immunotherapies is compromised by...
3.
Hamilton L, Moquin-Beaudry G, Mangahas C, Pratesi F, Aubin M, Aumont A, et al.
Nat Commun
. 2023 May;
14(1):2674.
PMID: 37160868
No abstract available.
4.
Moquin-Beaudry G, Marques Da Costa M, Gaspar N, Marchais A
Oncotarget
. 2023 Feb;
14:132.
PMID: 36780321
No abstract available.
5.
Moquin-Beaudry G, Benabdallah B, Maggiorani D, Le O, Li Y, Colas C, et al.
Cell Rep Methods
. 2022 Apr;
2(1):100153.
PMID: 35474871
Modeling the tumor-immune cell interactions in humanized mice is complex and limits drug development. Here, we generated easily accessible tumor models by transforming either primary skin fibroblasts or induced pluripotent...
6.
Hamilton L, Moquin-Beaudry G, Mangahas C, Pratesi F, Aubin M, Aumont A, et al.
Nat Commun
. 2022 Apr;
13(1):2061.
PMID: 35443751
The defining features of Alzheimer's disease (AD) include alterations in protein aggregation, immunity, lipid metabolism, synapses, and learning and memory. Of these, lipid abnormalities are the least understood. Here, we...
7.
Brunet-Ratnasingham E, Anand S, Gantner P, Dyachenko A, Moquin-Beaudry G, Brassard N, et al.
Sci Adv
. 2021 Nov;
7(48):eabj5629.
PMID: 34826237
Despite advances in COVID-19 management, identifying patients evolving toward death remains challenging. To identify early predictors of mortality within 60 days of symptom onset (DSO), we performed immunovirological assessments on...
8.
Moquin-Beaudry G, Colas C, Li Y, Bazin R, Guimond J, Haddad E, et al.
J Immunol
. 2019 Oct;
203(10):2735-2745.
PMID: 31578272
Therapeutic uses of mesenchymal stromal cells (MSCs) have emerged over the past decade. Yet, their effect on tumor growth remains highly debated, particularly in an immune competent environment. In this...
9.
Da Costa E, Armaos G, McInnes G, Beaudry A, Moquin-Beaudry G, Bertrand-Lehouillier V, et al.
J Exp Clin Cancer Res
. 2019 Jun;
38(1):251.
PMID: 31196146
Background: Cardiac glycosides are approved for the treatment of heart failure as Na/K pump inhibitors. Their repurposing in oncology is currently investigated in preclinical and clinical studies. However, the identification...
10.
Palacio L, Goyer M, Maggiorani D, Espinosa A, Villeneuve N, Bourbonnais S, et al.
Aging Cell
. 2019 Jun;
18(4):e12971.
PMID: 31148373
Some studies show eliminating senescent cells rejuvenate aged mice and attenuate deleterious effects of chemotherapy. Nevertheless, it remains unclear whether senescence affects immune cell function. We provide evidence that exposure...